239 related articles for article (PubMed ID: 25645694)
41. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
Fortin M; Hugo P
Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
[TBL] [Abstract][Full Text] [Related]
42. Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF).
Smets T; Stevenaert F; Adams HC; Vanhoof G
Methods Mol Biol; 2018; 1792():47-54. PubMed ID: 29797251
[TBL] [Abstract][Full Text] [Related]
43. Acquisition, Processing, and Quality Control of Mass Cytometry Data.
Lee BH; Rahman AH
Methods Mol Biol; 2019; 1989():13-31. PubMed ID: 31077096
[TBL] [Abstract][Full Text] [Related]
44. Characterizing Phenotypes and Signaling Networks of Single Human Cells by Mass Cytometry.
Leelatian N; Diggins KE; Irish JM
Methods Mol Biol; 2015; 1346():99-113. PubMed ID: 26542718
[TBL] [Abstract][Full Text] [Related]
45. A Carrier Strategy for Mass Cytometry Analysis of Small Numbers of Cells.
Jia X; Zhou X; Zheng H; Jiang S; Weng J; Huang L; Du Z; Xiao C; Zhang L; Chen XL; Fu G
Methods Mol Biol; 2020; 2111():21-33. PubMed ID: 31933195
[TBL] [Abstract][Full Text] [Related]
46. Fluorescent genetic barcoding in mammalian cells for enhanced multiplexing capabilities in flow cytometry.
Smurthwaite CA; Hilton BJ; O'Hanlon R; Stolp ZD; Hancock BM; Abbadessa D; Stotland A; Sklar LA; Wolkowicz R
Cytometry A; 2014 Jan; 85(1):105-13. PubMed ID: 24700576
[TBL] [Abstract][Full Text] [Related]
47. Removing unwanted variation with CytofRUV to integrate multiple CyTOF datasets.
Trussart M; Teh CE; Tan T; Leong L; Gray DH; Speed TP
Elife; 2020 Sep; 9():. PubMed ID: 32894218
[TBL] [Abstract][Full Text] [Related]
48. A Simple, Versatile Antibody-Based Barcoding Method for Flow Cytometry.
Akkaya B; Miozzo P; Holstein AH; Shevach EM; Pierce SK; Akkaya M
J Immunol; 2016 Sep; 197(5):2027-38. PubMed ID: 27439517
[TBL] [Abstract][Full Text] [Related]
49. Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth.
Gaudillière B; Ganio EA; Tingle M; Lancero HL; Fragiadakis GK; Baca QJ; Aghaeepour N; Wong RJ; Quaintance C; El-Sayed YY; Shaw GM; Lewis DB; Stevenson DK; Nolan GP; Angst MS
Cytometry A; 2015 Sep; 87(9):817-29. PubMed ID: 26190063
[TBL] [Abstract][Full Text] [Related]
50. Flow cytometric differentiation of avian leukocytes and analysis of their intracellular cytokine expression.
De Boever S; Croubels S; Demeyere K; Lambrecht B; De Backer P; Meyer E
Avian Pathol; 2010 Feb; 39(1):41-6. PubMed ID: 20390535
[TBL] [Abstract][Full Text] [Related]
51. Average Overlap Frequency: A simple metric to evaluate staining quality and community identification in high dimensional mass cytometry experiments.
Amir ED; Guo XV; Mayovska O; Rahman AH
J Immunol Methods; 2018 Feb; 453():20-29. PubMed ID: 28882613
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Signaling Networks at the Single-Cell Level Using Mass Cytometry.
Bandyopadhyay S; Fisher DAC; Malkova O; Oh ST
Methods Mol Biol; 2017; 1636():371-392. PubMed ID: 28730492
[TBL] [Abstract][Full Text] [Related]
53. Mass Cytometry for the Characterization of Individual Cell Types in Ovarian Solid Tumors.
Gonzalez VD; Huang YW; Fantl WJ
Methods Mol Biol; 2022; 2424():59-94. PubMed ID: 34918287
[TBL] [Abstract][Full Text] [Related]
54. Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials.
Abrecht C; Hallisey M; Dennis J; Nazzaro M; Brainard M; Hathaway E; Schork AN; Hodi FS; Severgnini M; Baginska J
STAR Protoc; 2022 Jun; 3(2):101362. PubMed ID: 35573480
[TBL] [Abstract][Full Text] [Related]
55. Flow Cytometry and Mass Cytometry for Measuring the Immune Cell Infiltrate in Atherosclerotic Arteries.
Orecchioni M; Meyer MA; Hedrick CC; Ley K
Methods Mol Biol; 2022; 2419():779-800. PubMed ID: 35238001
[TBL] [Abstract][Full Text] [Related]
56. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
Pallis M; Syan J; Russell NH
Cytometry; 1999 Dec; 37(4):308-13. PubMed ID: 10547616
[TBL] [Abstract][Full Text] [Related]
57. Cell analysis in cerebrospinal fluid (CSF) using Sysmex® hematology analyzers XT-4000i and XE-5000: evaluation with CSF controls of the Joint German Society for Clinical Chemistry and Laboratory Medicine (DGKL).
Kleine TO; Nebe CT; Löwer C; Geilenkeuser WJ; Dorn-Beineke A
Cytometry A; 2012 Mar; 81(3):255-64. PubMed ID: 22253065
[TBL] [Abstract][Full Text] [Related]
58. Single-Cell Profiling of the Intrinsic Apoptotic Pathway by Mass Cytometry (CyTOF).
Tan T; Gray DHD; Teh CE
Methods Mol Biol; 2022; 2543():83-97. PubMed ID: 36087261
[TBL] [Abstract][Full Text] [Related]
59. A single-platform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow transplantation.
Perruche S; Kleinclauss F; Lienard A; Robinet E; Tiberghien P; Saas P
J Immunol Methods; 2004 Nov; 294(1-2):53-66. PubMed ID: 15604016
[TBL] [Abstract][Full Text] [Related]
60. Titration of Mass Cytometry Reagents.
van Vreden C; Niewold P; McGuire HM; Fazekas de St Groth B
Methods Mol Biol; 2019; 1989():83-92. PubMed ID: 31077100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
